Recent Executive Recruitments
- All
- Academic/Medical
- Biotechnology
- Devices & Diagnostics
- Life Sciences
- Pharmaceutical
- Research & Development
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus...
Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their...
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that...
-
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD...
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their...
The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive...
The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals...
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive...
-
Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group
The Chase Group, known for relationship building with proven success in life sciences executive search,...
-
Biologics Consulting Leadership Team Grows Through Partnership with The Chase Group
Through focused collaboration with The Chase Group, Biologics Consulting has entered a season of growth...
The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology
Following an extensive search of industry and academic professionals by The Chase Group, the Allen...
-
The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics
After a comprehensive executive search that was filled in less than two months, The Chase...
-
The Chase Group Secures Director of Drug Safety in Copenhagen/Denmark for Genmab
As a result of their partnership with The Chase Group, Genmab has secured a Director,...
Partnership with The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
The Chase Group is proud to partner with Eisai and support their human health care...
Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team
To support their rapid growth and expanding portfolio of rare disease programs, Aeglea Biotherapeutics retained...
Eli Lilly Cyramza® Team Grows Through Continued Partnership with Chase
Utilizing their knowledge and years of experience recruiting in the life sciences industry, The Chase...
-
A New Era Begins with Head of Pathology Placement at Genmab
Dr. Suzana Couto joins Genmab Pharmaceuticals as Head of Pathology, leading the pathology teams located...
-
The Chase Group Makes Another Successful Placement at Eli Lilly
The Chase Group is pleased to continue our partnership with Eli Lilly in the successful...
-
Aeglea BioTherapeutics Builds Rare Disease Clinical Development Team Through Partnership with The Chase Group, Inc.
Through our ongoing partnership, Aeglea Biotherapeutics has secured a Vice President, Clinical Development, Rare Disease....
-
Eli Lilly Welcomes New Vice President, Immuno-Oncology Global & US Medical Affairs
The Chase Group is pleased to announce the placement of the Vice President, Immuno-Oncology Global...
The Chase Group Places VP of Clinical Development and Pharmacovigilance at Marinus Pharmaceuticals
The Chase Group is pleased to continue partnership with Marinus in building their leadership team...
-
The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly
The Chase Group is pleased to announce the successful completion of the Vice President, US...
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to...
-
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global...
-
A Successful Placement at Eisai, Inc.
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research,...
-
Another Successful Placement by The Chase Group at Marinus Pharmaceuticals
The Chase Group is pleased to announce the successful completion of the Executive Director, Head...
Another Key Placement by The Chase Group
Dr. Eliel Bayever Joins OncoQuest as Chief Medical Officer. We are so proud to connect...
-
The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals
The Chase Group appreciates and values our continued partnership with Ionis Pharmaceuticals and is pleased...
Corporate Communications Executive Secured for Ipsen Biopharmaceuticals
The Chase Group, Inc. is pleased to announce the successful completion of a search for...
Esperion Therapeutics Taps The Chase Group to Fill Newly Created Role
Esperion Therapeutics has retained The Chase Group, Inc. to secure an Executive Director, Project Management....
-
Vice President of Drug Safety for Ionis Pharmaceuticals Secured
The Chase Group announces another successful leadership recruitment with the placement of the Vice President...
-
Ionis Engages The Chase Group to Continue Building QA Team
Ionis Pharmaceuticals has retained The Chase Group, Inc. to help build their GCP QA team....
-
Ipsen Retains The Chase Group for Senior Marketers
Ipsen Biopharmaceuticals has retained The Chase Group once again to work with their commercial leadership...
-
Head of Regulatory Affairs Secured for Marinus
The Chase Group recently completed a highly competitive search for the Head of Regulatory Affairs...
The Chase Group Secures VP of Information Technology for Isis Pharmaceuticals
The Chase Group is proud to announce the completion of a search for a VP...
The Chase Group completes CMO search with Akcea Therapeutics
The Chase Group is proud to announce the completion of the Chief Medical Officer search...
AstraZeneca
AstraZeneca Oncology iSciences Retains The Chase Group for Chief Scientific Leadership Position Jul 15, 2015...
-
Eli Lilly
TCG completed another successful recruitment for Eli Lilly with the recent placement of an MD/PhD...
Entasis Therapeutics
The Chase Group proudly announces the successful completion of a search for the Chief Medical...
-
Isis Pharmaceuticals
Dr. Roger Lane was successfully recruited by The Chase Group to join Isis Pharmaceuticals as...
Acorda Therapeutics
The Chase Group is actively recruiting for a VP of Marketing for Acorda Therapeutics. This...
RRD International
The Chase Group proudly announces the successful completion of a search for the Chief Development...
-
Esperion Therapeutics
The Chase Group is proud to announce the successful completion of a search for a...
-
Ipsen Neurology
The Chase Group is proud to announce they recently completed a search for Vice President,...
-
Marinus Pharmaceuticals
The Chase Group is proud to announce the completion of a search for the Chief...
Abbvie
The Chase Group announces the recruitment of Toni Glinsey, joining the team at AbbVie as...
-
Akcea Therapeutics
Akcea Therapeutics has retained The Chase Group to secure a Chief Medical Officer to join...